Abstract
Tryptophan catabolism is a tolerogenic effector system in regulatory T cell function, yet the general mechanisms whereby tryptophan catabolism affects T cell responses remain unclear. We provide evidence that its effects include the emergence of a regulatory phenotype in naive CD4+CD25- cells via the general control non-depressing 2 (GCN2) protein kinase mediated induction of the forkhead transcription factor Foxp3. These cells are capable of effective control of diabetogenic T cells in vivo.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 58-60 |
| Number of pages | 3 |
| Journal | Transplant Immunology |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
- Transplantation
Fingerprint
Dive into the research topics of 'Tryptophan catabolism generates autoimmune-preventive regulatory T cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver